1. AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row

    AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row

    Pascal Soriot, as AstraZeneca Executive Director and CEO, during US Senate Finance Committee hearing on drug prices, graphic element on gray Amid mounting scrutiny of AstraZeneca's ( AZ.L ) COVID-19 vaccine, the company's CEO is facing pushback from shareholders over a potential big bump in bonuses. Pascal Soriot is in line for a windfall of between £2.3m ($3.2m) and £12m — a sum that could rise in line with AstraZeneca's share price...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned